脳腫瘍診断と治療の市場規模、シェア、動向分析レポート：タイプ別、製品別、診断別、治療別、最終用途別、地域別、セグメント別予測、2025年～2030年

脳腫瘍診断と治療市場の成長と動向

世界の脳腫瘍診断と治療市場規模は、2030年には49億4,000万米ドルに達すると予測され、2025～2030年にかけてCAGR 7.3％で成長すると予測されています。

この市場は、高齢者の増加と相まって、様々な脳腫瘍、特に膠芽腫の罹患率が増加しているため、予測期間中に有利な成長を遂げると予想されます。

医療セクターにおける官民パートナーシップ（PPP）の増加は、画像診断と放射線学サービスの近代化を進めており、この産業の拡大を支えています。Sodium Magnetic Resonance Imaging（23Na MRI）、Positron Emission Tomography（PET）、Chemical Exchange Saturation Transfer（CEST）などの新技術は、多施設共同臨床検査環境における脳腫瘍の反応を検出するために使用されています。さらに、これらの技術は治療に対する腫瘍の反応を定量的に画像化するのに有用であり、それによって治療中の使用を促進します。

これらの技術は、生理学や細胞代謝に関する情報を提供することで、解剖学的イメージングにとどまらずMRIを拡大し、診断効率を高める可能性を秘めています。そのため、同市場は予測期間中に生産的な成長を遂げると予想されます。

さらに、悪性腫瘍の細胞レベルでの細胞生物学を理解し、悪性腫瘍に関連する遺伝子変異を同定するための分子診断学の研究が進行中であり、産業の成長に大きく貢献すると予想されます。

一方、脳腫瘍診断にかかる費用は450～1万2,200米ドルと高額であるため、世界の脳腫瘍診断市場の成長を妨げる可能性が高いです。

脳腫瘍診断と治療市場レポートハイライト

• 画像診断技術の進歩により、市場内の機能が大幅に強化されました。
• 主要セグメントは市場を独占し、2024年には62.7%のシェアを占めます。
• ステイン＆ワニスが市場をリードし、2024年のシェアは25.7％。
• CTスキャンは2024年に25.8%の売上シェアを占め、市場を独占しました。
• 外科手術は2024年に35.6%の最大シェアを占めました。
• 腫瘍治療センターが2024年に48.5％の最大市場シェアを占めました。
• 北米の脳腫瘍診断・治療市場は、2024年に41.9％の収益シェアで世界市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 脳腫瘍診断と治療市場の変数、動向、範囲

• 市場系統の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ビジネス環境分析
  • 産業分析-ポーターのファイブフォース分析
  • PESTLE分析

第4章 脳腫瘍診断と治療市場：タイプビジネス分析

• タイプ市場シェア、2024年と2030年
• タイプセグメントダッシュボード
• 市場規模と予測と動向分析、タイプ別、2018～2030年
• 一次
• 二次

第5章 脳腫瘍診断と治療市場：製品ビジネス分析

• 製品市場シェア、2024年と2030年
• 製品セグメントダッシュボード
• 市場規模と予測と動向分析、製品別、2018～2030年
• ステインとワニス
• シェラック
• ラッカー
• その他

第6章 脳腫瘍診断と治療市場：診断ビジネス分析

• 診断市場シェア、2024年と2030年
• 診断セグメントダッシュボード
• 市場規模と予測と動向分析、診断別、2018～2030年
• MRI
• CTスキャン
• 組織サンプル採取
• PET-CTスキャン
• 脳動脈造影
• 腰椎穿刺
• 分子検査
• 脳波
• その他

第7章 脳腫瘍診断と治療市場：治療ビジネス分析

• 治療市場シェア、2024年と2030年
• 治療セグメントダッシュボード
• 市場規模と予測と動向分析、治療別、2018～2030年
• 手術
• 放射線治療
• 化学療法
• 免疫療法
• 標的療法
• その他

第8章 脳腫瘍診断と治療市場：最終用途ビジネス分析

• 最終用途市場シェア、2024年と2030年
• 最終用途セグメントダッシュボード
• 市場規模と予測と動向分析、最終用途別、2018～2030年
• 病院
• 腫瘍治療センター
• その他

第9章 脳腫瘍診断と治療市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 国別、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 国別、2018～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • デンマーク
  • スウェーデン
• アジア太平洋
  • 国別、2018～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • 国別、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 国別、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Amgen Inc.
  • AstraZeneca
  • Bayer Corporation
  • GE HealthCare
  • F. Hoffmann-La Roche Ltd
  • Eisai Co., Ltd.
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Shimadzu Corporation
  • Siemens Healthineers AG

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global brain tumor diagnosis and therapeutics market, by region, 2018 - 2030 (USD Million)
• Table 4 Global brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 5 Global brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 6 Global brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 7 Global brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 8 Global brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 9 North America brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
• Table 10 North America brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 11 North America brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 12 North America brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 13 North America brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 14 North America brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 15 U.S. brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 16 U.S. brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 17 U.S. brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 18 U.S. brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 19 U.S. brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 20 Canada brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 21 Canada brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 22 Canada brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 23 Canada brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 24 Canada brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 25 Europe brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
• Table 26 Mexico brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 27 Mexico brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 28 Mexico brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 29 Mexico brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 30 Mexico brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 31 Europe brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 32 Europe brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 33 Europe brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 34 Europe brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 35 Europe brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 36 UK brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 37 UK brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 38 UK brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 39 UK brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 40 UK brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 41 Germany brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 42 Germany brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 43 Germany brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 44 Germany brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 45 Germany brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 46 France brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 47 France brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 48 France brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 49 France brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 50 France brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 51 Italy brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 52 Italy brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 53 Italy brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 54 Italy brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 55 Italy brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 56 Spain brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 57 Spain brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 58 Spain brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 59 Spain brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 60 Spain brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 61 Denmark brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 62 Denmark brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 63 Denmark brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 64 Denmark brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 65 Denmark brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 66 Sweden brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 67 Sweden brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 68 Sweden brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 69 Sweden brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 70 Sweden brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 71 Norway brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 72 Norway brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 73 Norway brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 74 Norway brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 75 Norway brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 80 Asia Pacific brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 81 Asia Pacific brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 82 China brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 83 China brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 84 China brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 85 China brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 86 China brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 87 Japan brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 88 Japan brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 89 Japan brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 90 Japan brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 91 Japan brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 92 India brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 93 India brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 94 India brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 95 India brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 96 India brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 97 Australia brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 98 Australia brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 99 Australia brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 100 Australia brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 101 Australia brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 102 South Korea brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 103 South Korea brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 104 South Korea brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 105 South Korea brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 106 South Korea brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 107 Thailand brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 108 Thailand brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 109 Thailand brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 110 Thailand brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 111 Thailand brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 112 Latin America brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
• Table 113 Latin America brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 114 Latin America brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 115 Latin America brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 116 Latin America brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 117 Latin America brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 118 Brazil brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 119 Brazil brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 120 Brazil brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 121 Brazil brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 122 Brazil brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 123 Argentina brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 124 Argentina brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 125 Argentina brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 126 Argentina brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 127 Argentina brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 128 Middle East & Africa Brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
• Table 129 Middle East & Africa brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 130 Middle East & Africa brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 131 Middle East & Africa brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 132 Middle East & Africa brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 133 Middle East & Africa brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 134 South Africa brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 135 South Africa brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 136 South Africa brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 137 South Africa brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 138 South Africa brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 143 Saudi Arabia brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 144 UAE brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 145 UAE brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 146 UAE brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 147 UAE brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 148 UAE brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
• Table 149 Kuwait brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
• Table 150 Kuwait brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
• Table 151 Kuwait brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
• Table 152 Kuwait brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
• Table 153 Kuwait brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Brain tumor diagnosis and therapeutics market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Type and product outlook (USD Million)
• Fig. 10 Diagnosis and therapeutics outlook (USD Million)
• Fig. 11 End use outlook (USD Million)
• Fig. 12 Competitive landscape
• Fig. 13 Brain tumor diagnosis and therapeutics market dynamics
• Fig. 14 Brain tumor diagnosis and therapeutics market: Porter's five forces analysis
• Fig. 15 Brain tumor diagnosis and therapeutics market: PESTLE analysis
• Fig. 16 Brain tumor diagnosis and therapeutics market: Type segment dashboard
• Fig. 17 Brain tumor diagnosis and therapeutics market: Type market share analysis, 2024 & 2030
• Fig. 18 Primary market, 2018 - 2030 (USD Million)
• Fig. 19 Meningioma market, 2018 - 2030 (USD Million)
• Fig. 20 Gliomas market, 2018 - 2030 (USD Million)
• Fig. 21 Astrocytomas market, 2018 - 2030 (USD Million)
• Fig. 22 Pituitary tumors market, 2018 - 2030 (USD Million)
• Fig. 23 Others market, 2018 - 2030 (USD Million)
• Fig. 24 Secondary market, 2018 - 2030 (USD Million)
• Fig. 25 Brain tumor diagnosis and therapeutics market: Product segment dashboard
• Fig. 26 Brain tumor diagnosis and therapeutics market: Product market share analysis, 2024 & 2030
• Fig. 27 Stains & varnishes market, 2018 - 2030 (USD Million)
• Fig. 28 Shellacs market, 2018 - 2030 (USD Million)
• Fig. 29 Lacquers market, 2018 - 2030 (USD Million)
• Fig. 30 Others market, 2018 - 2030 (USD Million)
• Fig. 31 Brain tumor diagnosis and therapeutics market: Diagnosis segment dashboard
• Fig. 32 Brain tumor diagnosis and therapeutics market: Diagnosis market share analysis, 2024 & 2030
• Fig. 33 MRI market, 2018 - 2030 (USD Million)
• Fig. 34 CT scan market, 2018 - 2030 (USD Million)
• Fig. 35 Tissue sampling market, 2018 - 2030 (USD Million)
• Fig. 36 PET-CT scan market, 2018 - 2030 (USD Million)
• Fig. 37 Cerebral arteriogram market, 2018 - 2030 (USD Million)
• Fig. 38 Lumbar puncture market, 2018 - 2030 (USD Million)
• Fig. 39 Molecular testing market, 2018 - 2030 (USD Million)
• Fig. 40 EEG market, 2018 - 2030 (USD Million)
• Fig. 41 Others market, 2018 - 2030 (USD Million)
• Fig. 42 Brain tumor diagnosis and therapeutics market: Therapeutics segment dashboard
• Fig. 43 Brain tumor diagnosis and therapeutics market: Therapeutics market share analysis, 2024 & 2030
• Fig. 44 Surgery market, 2018 - 2030 (USD Million)
• Fig. 45 Radiation therapy market, 2018 - 2030 (USD Million)
• Fig. 46 Chemotherapy market, 2018 - 2030 (USD Million)
• Fig. 47 Immunotherapy market, 2018 - 2030 (USD Million)
• Fig. 48 Targeted therapy market, 2018 - 2030 (USD Million)
• Fig. 49 Others market, 2018 - 2030 (USD Million)
• Fig. 50 Brain tumor diagnosis and therapeutics market: End use segment dashboard
• Fig. 51 Brain tumor diagnosis and therapeutics market: End use market share analysis, 2024 & 2030
• Fig. 52 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 53 Oncology treatment centers market, 2018 - 2030 (USD Million)
• Fig. 54 Others market, 2018 - 2030 (USD Million)
• Fig. 55 Brain tumor diagnosis and therapeutics market revenue, by region
• Fig. 56 Regional marketplace: Key takeaways
• Fig. 57 Regional marketplace: Key takeaways
• Fig. 58 North America brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 59 U.S. country dynamics
• Fig. 60 U.S. brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 61 Canada country dynamics
• Fig. 62 Canada brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 63 Mexico country dynamics
• Fig. 64 Mexico brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 65 Europe brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 66 UK country dynamics
• Fig. 67 UK brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 68 Germany country dynamics
• Fig. 69 Germany brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 70 France country dynamics
• Fig. 71 France brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 72 Italy country dynamics
• Fig. 73 Italy brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 74 Spain country dynamics
• Fig. 75 Spain brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 76 Norway country dynamics
• Fig. 77 Norway brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 78 Sweden country dynamics
• Fig. 79 Sweden brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 80 Denmark country dynamics
• Fig. 81 Denmark brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 82 Asia Pacific brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 83 Japan country dynamics
• Fig. 84 Japan brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 85 China country dynamics
• Fig. 86 China brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 87 India country dynamics
• Fig. 88 India brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 89 Australia country dynamics
• Fig. 90 Australia brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 91 South Korea country dynamics
• Fig. 92 South Korea brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 93 Thailand country dynamics
• Fig. 94 Thailand brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 95 Latin America brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 96 Brazil country dynamics
• Fig. 97 Brazil brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 98 Argentina country dynamics
• Fig. 99 Argentina brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 100 MEA brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 101 South Africa country dynamics
• Fig. 102 South Africa brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 103 Saudi Arabia country dynamics
• Fig. 104 Saudi Arabia brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 105 UAE country dynamics
• Fig. 106 UAE brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 107 Kuwait country dynamics
• Fig. 108 Kuwait brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
• Fig. 109 Company categorization
• Fig. 110 Company market position analysis
• Fig. 111 Strategic framework

Brain Tumor Diagnosis And Therapeutics Market Growth & Trends:

The global brain tumor diagnosis and therapeutics market size is expected to reach USD 4.94 billion in 2030 and is projected to grow at a CAGR of 7.3% from 2025 to 2030. The market is expected to pose lucrative growth over the forecast period, owing to the increasing incidence of various brain cancers, particularly glioblastoma, coupled with the rising geriatric population.

Increasing Public-Private Partnerships (PPPs) in the health sector, which are modernizing diagnostic imaging and radiology services, are supporting the expansion of this industry. Emerging technologies like Sodium Magnetic Resonance Imaging(23Na MRI), Positron Emission Tomography (PET), and Chemical Exchange Saturation Transfer (CEST) are used to detect the response of brain tumors in multicenter clinical trial settings. In addition, these technologies are helpful in quantitatively imaging tumor response to therapies, thereby promoting their use during treatment.

These technologies have the potential to extend MRI beyond anatomical imaging by providing information on physiology and cellular metabolism, thereby increasing the efficiency of diagnosis. Hence, the market is expected to witness productive growth over the forecast period.

Moreover, ongoing research in molecular diagnostics to understand cell biology at the cellular level of malignancy and identification of gene mutations associated with malignancy is anticipated to significantly contribute toward the growth of the industry.

On the other hand, the high cost of diagnosing brain tumors, which ranges from USD 450 to 12,200, is likely to hinder the growth of the global brain tumor diagnosis market.

Brain Tumor Diagnosis And Therapeutics Market Report Highlights:

• Advancements in diagnostic imaging technologies have significantly enhanced the capabilities within the market
• The primary segment dominated the market and accounted for a share of 62.7% in 2024
• Stains & varnishes led the market and accounted for a share of 25.7% in 2024
• CT scan dominated the market with a revenue share of 25.8% in 2024
• Surgery held the largest market share of 35.6% in 2024
• Oncology treatment centers held the largest market share of 48.5% in 2024
• North America brain tumor diagnosis and therapeutics market dominated the global market with a revenue share of 41.9% in 2024

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Product
  • 1.2.3. Diagnosis
  • 1.2.4. Therapeutics
  • 1.2.5. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Brain Tumor Diagnosis and Therapeutics Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Brain Tumor Diagnosis and Therapeutics Market: Type Business Analysis

• 4.1. Type Market Share, 2024 & 2030
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Primary
  • 4.4.1. Primary Market, 2018 - 2030 (USD Million)
  • 4.4.2. Meningioma
    • 4.4.2.1. Meningioma Market, 2018 - 2030 (USD Million)
  • 4.4.3. Gliomas
    • 4.4.3.1. Gliomas Market, 2018 - 2030 (USD Million)
  • 4.4.4. Astrocytomas
    • 4.4.4.1. Astrocytomas Market, 2018 - 2030 (USD Million)
  • 4.4.5. Pituitary Tumors
    • 4.4.5.1. Pituitary Tumors Market, 2018 - 2030 (USD Million)
  • 4.4.6. Others
    • 4.4.6.1. Others Market, 2018 - 2030 (USD Million)
• 4.5. Secondary
  • 4.5.1. Secondary Market, 2018 - 2030 (USD Million)

Chapter 5. Brain Tumor Diagnosis and Therapeutics Market: Product Business Analysis

• 5.1. Product Market Share, 2024 & 2030
• 5.2. Product Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 5.4. Stains & Varnishes
  • 5.4.1. Stains & Varnishes Market, 2018 - 2030 (USD Million)
• 5.5. Shellacs
  • 5.5.1. Shellacs Market, 2018 - 2030 (USD Million)
• 5.6. Lacquers
  • 5.6.1. Lacquers Market, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Brain Tumor Diagnosis and Therapeutics Market: Diagnosis Business Analysis

• 6.1. Diagnosis Market Share, 2024 & 2030
• 6.2. Diagnosis Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Diagnosis, 2018 to 2030 (USD Million)
• 6.4. MRI
  • 6.4.1. MRI Market, 2018 - 2030 (USD Million)
• 6.5. CT Scan
  • 6.5.1. CT Scan Market, 2018 - 2030 (USD Million)
• 6.6. Tissue Sampling
  • 6.6.1. Tissue Sampling Market, 2018 - 2030 (USD Million)
• 6.7. PET-CT scan
  • 6.7.1. PET-CT scan Market, 2018 - 2030 (USD Million)
• 6.8. Cerebral Arteriogram
  • 6.8.1. Cerebral Arteriogram Market, 2018 - 2030 (USD Million)
• 6.9. Lumbar Puncture
  • 6.9.1. Lumbar Puncture Market, 2018 - 2030 (USD Million)
• 6.10. Molecular Testing
  • 6.10.1. Molecular Testing Market, 2018 - 2030 (USD Million)
• 6.11. EEG
  • 6.11.1. EEG Market, 2018 - 2030 (USD Million)
• 6.12. Others
  • 6.12.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Brain Tumor Diagnosis and Therapeutics Market: Therapeutics Business Analysis

• 7.1. Therapeutics Market Share, 2024 & 2030
• 7.2. Therapeutics Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, by Therapeutics, 2018 to 2030 (USD Million)
• 7.4. Surgery
  • 7.4.1. Surgery Market, 2018 - 2030 (USD Million)
• 7.5. Radiation Therapy
  • 7.5.1. Radiation Therapy Market, 2018 - 2030 (USD Million)
• 7.6. Chemotherapy
  • 7.6.1. Chemotherapy Market, 2018 - 2030 (USD Million)
• 7.7. Immunotherapy
  • 7.7.1. Immunotherapy Market, 2018 - 2030 (USD Million)
• 7.8. Targeted Therapy
  • 7.8.1. Targeted Therapy Market, 2018 - 2030 (USD Million)
• 7.9. Others
  • 7.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Brain Tumor Diagnosis and Therapeutics Market: End Use Business Analysis

• 8.1. End Use Market Share, 2024 & 2030
• 8.2. End Use Segment Dashboard
• 8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 8.4. Hospitals
  • 8.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 8.5. Oncology Treatment Centers
  • 8.5.1. Oncology Treatment Centers Market, 2018 - 2030 (USD Million)
• 8.6. Others
  • 8.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Brain Tumor Diagnosis and Therapeutics Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.4. North America
  • 9.4.1. North America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Regulatory Framework
    • 9.4.2.3. Competitive Insights
    • 9.4.2.4. U.S. Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Regulatory Framework
    • 9.4.3.3. Competitive Insights
    • 9.4.3.4. Canada Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Regulatory Framework
    • 9.4.4.3. Competitive Insights
    • 9.4.4.4. Mexico Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Regulatory Framework
    • 9.5.2.3. Competitive Insights
    • 9.5.2.4. UK Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Regulatory Framework
    • 9.5.3.3. Competitive Insights
    • 9.5.3.4. Germany Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Regulatory Framework
    • 9.5.4.3. Competitive Insights
    • 9.5.4.4. France Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Regulatory Framework
    • 9.5.5.3. Competitive Insights
    • 9.5.5.4. Italy Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Regulatory Framework
    • 9.5.6.3. Competitive Insights
    • 9.5.6.4. Spain Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. Norway
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Regulatory Framework
    • 9.5.7.3. Competitive Insights
    • 9.5.7.4. Norway Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.8. Denmark
    • 9.5.8.1. Key Country Dynamics
    • 9.5.8.2. Regulatory Framework
    • 9.5.8.3. Competitive Insights
    • 9.5.8.4. Denmark Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.9. Sweden
    • 9.5.9.1. Key Country Dynamics
    • 9.5.9.2. Regulatory Framework
    • 9.5.9.3. Competitive Insights
    • 9.5.9.4. Sweden Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Regulatory Framework
    • 9.6.2.3. Competitive Insights
    • 9.6.2.4. Japan Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Regulatory Framework
    • 9.6.3.3. Competitive Insights
    • 9.6.3.4. China Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Regulatory Framework
    • 9.6.4.3. Competitive Insights
    • 9.6.4.4. India Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5. South Korea
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Regulatory Framework
    • 9.6.5.3. Competitive Insights
    • 9.6.5.4. South Korea Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.6. Australia
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. Regulatory Framework
    • 9.6.6.3. Competitive Insights
    • 9.6.6.4. Australia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Regulatory Framework
    • 9.6.7.3. Competitive Insights
    • 9.6.7.4. Thailand Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Regulatory Framework
    • 9.7.2.3. Competitive Insights
    • 9.7.2.4. Brazil Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Regulatory Framework
    • 9.7.3.3. Competitive Insights
    • 9.7.3.4. Argentina Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.8. MEA
  • 9.8.1. MEA Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key Country Dynamics
    • 9.8.2.2. Regulatory Framework
    • 9.8.2.3. Competitive Insights
    • 9.8.2.4. South Africa Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key Country Dynamics
    • 9.8.3.2. Regulatory Framework
    • 9.8.3.3. Competitive Insights
    • 9.8.3.4. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key Country Dynamics
    • 9.8.4.2. Regulatory Framework
    • 9.8.4.3. Competitive Insights
    • 9.8.4.4. UAE Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key Country Dynamics
    • 9.8.5.2. Regulatory Framework
    • 9.8.5.3. Competitive Insights
    • 9.8.5.4. Kuwait Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Overview
• 10.2. Company Market Position Analysis
• 10.3. Company Categorization
• 10.4. Strategy Mapping
• 10.5. Company Profiles/Listing
  • 10.5.1. Amgen Inc.
    • 10.5.1.1. Overview
    • 10.5.1.2. Financial Performance
    • 10.5.1.3. Product Benchmarking
    • 10.5.1.4. Strategic Initiatives
  • 10.5.2. AstraZeneca
    • 10.5.2.1. Overview
    • 10.5.2.2. Financial Performance
    • 10.5.2.3. Product Benchmarking
    • 10.5.2.4. Strategic Initiatives
  • 10.5.3. Bayer Corporation
    • 10.5.3.1. Overview
    • 10.5.3.2. Financial Performance
    • 10.5.3.3. Product Benchmarking
    • 10.5.3.4. Strategic Initiatives
  • 10.5.4. GE HealthCare
    • 10.5.4.1. Overview
    • 10.5.4.2. Financial Performance
    • 10.5.4.3. Product Benchmarking
    • 10.5.4.4. Strategic Initiatives
  • 10.5.5. F. Hoffmann-La Roche Ltd
    • 10.5.5.1. Overview
    • 10.5.5.2. Financial Performance
    • 10.5.5.3. Product Benchmarking
    • 10.5.5.4. Strategic Initiatives
  • 10.5.6. Eisai Co., Ltd.
    • 10.5.6.1. Overview
    • 10.5.6.2. Financial Performance
    • 10.5.6.3. Product Benchmarking
    • 10.5.6.4. Strategic Initiatives
  • 10.5.7. Bristol-Myers Squibb Company
    • 10.5.7.1. Overview
    • 10.5.7.2. Financial Performance
    • 10.5.7.3. Product Benchmarking
    • 10.5.7.4. Strategic Initiatives
  • 10.5.8. Pfizer Inc.
    • 10.5.8.1. Overview
    • 10.5.8.2. Financial Performance
    • 10.5.8.3. Product Benchmarking
    • 10.5.8.4. Strategic Initiatives
  • 10.5.9. Shimadzu Corporation
    • 10.5.9.1. Overview
    • 10.5.9.2. Financial Performance
    • 10.5.9.3. Product Benchmarking
    • 10.5.9.4. Strategic Initiatives
  • 10.5.10. Siemens Healthineers AG
    • 10.5.10.1. Overview
    • 10.5.10.2. Financial Performance
    • 10.5.10.3. Product Benchmarking
    • 10.5.10.4. Strategic Initiatives